inflammatori
storm
incit
monocyt
centric
immun
interact
reveal
singlecel
analysi
network
tocilizumab
treatment
singl
cell
resolut
uncov
apr
report
death
confirm
case
infect
sever
acut
respiratori
syndrom
coronaviru
number
still
grow
rapidli
approxim
patient
experienc
sever
diseas
critic
ill
suffer
fatal
rate
may
caus
patient
abnorm
immun
system
activ
henc
urgent
need
research
understand
immun
system
respond
viral
infect
sever
stage
therebi
provid
effect
treatment
strategi
studi
shown
inflammatori
storm
caus
excess
immun
respons
associ
crucial
caus
mortal
plasma
concentr
seri
inflammatori
cytokin
granulocytemacrophag
colonystimul
factor
gmcsf
interleukin
il
tumor
necrosi
factor
granulocyt
colonystimul
factor
gcsf
increas
infect
investig
demonstr
peripher
inflammatori
monocyt
pathogen
cell
may
incit
cytokin
storm
sever
patient
calm
inflammatori
storm
tocilizumab
target
receptor
prove
effect
treatment
cytokin
releas
syndrom
sever
lifethreaten
use
treatment
sever
receiv
tocilizumab
bodi
temperatur
patient
return
normal
hour
concentr
oxygen
inhal
significantli
decreas
th
day
howev
immun
network
arous
inflammatori
storm
sever
recoveri
stage
tocilizumab
therapi
singl
cell
level
uncov
profil
peripher
immun
cell
patient
use
cell
transcriptom
sequenc
obtain
peripher
blood
sampl
sever
patient
consecut
timepoint
sever
recoveri
stage
tocilizumab
treatment
fig
specif
blood
sampl
sever
stage
collect
within
hour
tocilizumab
given
blood
sampl
recoveri
stage
collect
th
th
day
tocilizumab
treatment
monocyt
subpopul
suppress
tocilizumab
treatment
next
explor
transcript
factor
tf
may
involv
regul
inflammatori
storm
monocyt
use
scenic
predict
tf
may
regul
gene
enrich
sever
stagespecif
monocyt
fig
construct
gene
regulatori
network
found
name
regul
cytokin
storm
relev
gene
extend
data
addit
found
express
target
gene
enhanc
severespecif
monocyt
subpopul
fig
suggest
tf
may
regul
inflammatori
storm
monocyt
given
monocyt
sever
stage
may
involv
regul
varieti
immun
cell
type
use
accumul
ligandreceptor
interact
databas
cellphonedb
wwwcellphonedborg
identifi
alter
molecular
interact
monocyt
immun
cell
subset
supplementari
tabl
found
pair
cytokin
receptor
whose
interact
significantli
alter
sever
versu
recoveri
healthi
stage
fig
consist
previou
studi
found
monocyt
interact
cell
plasma
b
cell
patient
sever
stage
ligandreceptor
pair
interact
togeth
mani
cytokin
storm
relev
cellcel
commun
extens
attenu
treatment
tocilizumab
fig
suggest
drug
may
function
effect
block
inflammatori
storm
sever
addit
also
discov
mani
ligandreceptor
pair
involv
broader
spectrum
immun
cell
commun
enrich
sever
stage
exampl
receptor
connect
monocyt
mani
immun
cell
other
like
receptor
connect
monocyt
cell
chemokin
receptor
also
found
enrich
sever
stage
cytokin
receptor
may
serv
potenti
drug
target
treat
patient
sever
stage
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
inhibitor
undergo
clinic
trial
multipl
place
around
world
supplementari
tabl
collect
find
illustr
molecular
basi
cellcel
interact
peripher
blood
patient
lead
better
understand
mechan
inflammatori
storm
diseas
robust
multifactori
immun
respons
elicit
viral
infect
avian
diseas
recent
report
found
effect
immun
respons
nonsever
patient
howev
clear
whether
antiviru
immun
respons
would
affect
tocilizumab
treatment
therefor
viru
immun
respons
humor
cellmedi
immun
patient
sever
stage
compar
recoveri
stage
healthi
control
expect
found
plasma
b
cell
bare
exist
healthi
control
fig
subset
cell
prolifer
characterist
cluster
fig
among
cell
sever
patient
mainli
distribut
effector
cell
cluster
fig
conduct
pairwis
comparison
identifi
deg
cell
sever
recoveri
healthi
stage
tabl
p
meanwhil
gene
involv
leukocyt
mediat
cytotox
posit
regul
cytokin
product
highli
enrich
cell
patient
sever
recoveri
stage
fig
supplementari
tabl
p
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
detect
elev
express
gene
involv
go
term
fig
supplementari
tabl
togeth
result
demonstr
critic
evid
robust
adapt
immun
respons
infect
exist
sever
stage
remain
tocilizumab
treatment
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
peripher
blood
sampl
obtain
two
sever
patient
gener
singlecel
transcriptom
librari
follow
instruct
singlecel
solut
reagent
kit
genom
briefli
thaw
wash
count
cell
load
cell
suspens
onto
chromium
singlecel
chip
along
partit
oil
revers
transcript
rt
reagent
collect
gel
bead
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
contain
uniqu
barcod
gener
singlecel
gel
emuls
gem
rt
perform
use
touch
tm
thermal
cycler
rad
amplifi
cdna
purifi
spriselect
bead
beckman
coulter
singlecel
librari
construct
follow
fragment
end
repair
tail
adaptor
ligat
size
select
base
manufactur
standard
paramet
sequenc
librari
gener
uniqu
sampl
index
librari
sequenc
illumina
novaseq
system
access
number
avail
upon
request
also
use
scrnaseq
data
pbmc
healthi
donor
download
genom
offici
websit
firstli
filter
low
qualiti
cell
use
seurat
version
cell
patient
pz
pw
retain
cell
detect
gene
number
mitochondri
umi
less
cell
healthi
donor
retain
cell
detect
gene
number
mitochondri
umi
less
subsequ
normal
gene
count
cell
use
normalizedata
function
seurat
default
paramet
downstream
data
process
use
canon
correl
analysi
cca
top
canon
compon
find
anchor
cell
patient
healthi
control
use
integratedata
function
seurat
integr
cell
cluster
cell
base
integr
dataset
use
seurat
paramet
gener
cluster
display
cell
space
ran
princip
compon
analysi
pca
integr
dataset
adopt
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
first
princip
compon
uniform
manifold
approxim
project
umap
analysi
search
differenti
express
gene
deg
first
assign
neg
element
integr
express
matrix
zero
use
wilcoxon
ranksum
test
search
deg
pair
stage
cell
ie
sever
stage
recoveri
stage
healthi
control
appli
multipl
threshold
screen
deg
includ
mean
foldchang
p
valu
detect
cell
least
one
stage
adopt
scenic
version
rcistarget
databas
build
gene
regulatori
network
monocyt
sinc
number
monocyt
healthi
control
n
sever
recoveri
stage
n
balanc
contribut
motif
analysi
randomli
sampl
monocyt
healthi
control
calcul
select
gene
detect
least
monocyt
includ
deg
stage
input
featur
scenic
default
paramet
scenic
gener
enrich
score
motif
use
student
ttest
calcul
p
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
valu
motif
sever
stage
healthi
control
select
specif
enrich
motif
fold
chang
p
valu
appli
enrich
score
severespecif
enrich
motif
express
target
gene
cytoscap
construct
connect
map
upload
scrnaseq
data
pbmc
sever
patient
genom
sequenc
archiv
big
data
center
access
number
avail
upon
request
also
use
scrnaseq
data
pbmc
healthi
donor
download
genom
offici
websit
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
recoveri
stage
b
healthi
control
c
nk
l
l
r
n
f
v
r
n
f
n
f
r
f
b
n
f
n
f
r
f
l
b
r
b
c
c
l
c
x
c
r
f
l
l
g
f
l
c
c
l
l
f
f
r
c
c
l
l
v
r
c
c
l
l
p
g
r
c
c
c
l
l
c
c
r
c
c
l
c
n
r
c
c
l
l
c
c
c
l
c
c
r
n
f
f
f
r
log
express
log
pvalu
low
high
c
healthi
control
r
recoveri
stage
sever
stage
sever
stage
recoveri
stage
healthi
control
log
pvalu
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
naiv
effector
ighm
igkc
faslg
gzmb
tnf
